Search research articles
Contact Us
Filters
Showing results (81-90 of 171) with videos related to
Page
of 18
Sort By:
Chemosphere
|
April 22, 2018
A swinging seesaw as a novel model mechanism for time-dependent hormesis under dose-dependent stimulatory and inhibitory effects: A case study on the toxicity of antibacterial chemicals to Aliivibrio fischeri
Haoyu Sun, Edward J Calabrese, Min Zheng, et al.
International Journal of Biological Macromolecules
|
April 1, 2025
Polydopamine-mediated biointerfacial nanozyme as probiotic protective coating for IBD therapy
Tong Zhang, Chen Wang, Ting Du, et al.
Cancer Biology & Medicine
|
December 10, 2020
Trispecific killer engager 161519 enhances natural killer cell function and provides anti-tumor activity against CD19-positive cancers
Ying Cheng, Xiaodong Zheng, Xuefu Wang, et al.
Disease Markers
|
March 18, 2022
Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma
Hongda Guo, Songlin Jiang, Haoyu Sun, et al.
Frontiers in Immunology
|
April 28, 2023
Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager
Xinghui Xiao, Ying Cheng, Xiaodong Zheng, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
July 25, 2025
Investigation into the acute effects of various waveforms on tibial nerve stimulation for treating overactive bladder in cats
Dongsheng Shang, Haoyu Sun, Han Deng, et al.
Cancer Immunology Research
|
November 21, 2024
CD49a Targeting Enhances NK Cell Function and Antitumor Immunity
Yu Zhang, Yangyang Li, Zhengfeng Zhang, et al.
Frontiers in Immunology
|
January 31, 2024
Corrigendum: Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager
Xinghui Xiao, Ying Cheng, Xiaodong Zheng, et al.
Frontiers in Pharmacology
|
April 30, 2025
Safety and efficacy of intravesical instillation of botulinum toxin-A in the treatment of interstitial cystitis/bladder pain syndrome and overactive bladder: a systematic review and meta-analysis
Yongheng Zhou, Zitian He, Tianyu Xiang, et al.
JCI Insight
|
July 8, 2024
Hepatocyte-derived FGL1 accelerates liver metastasis and tumor growth by inhibiting CD8+ T and NK cells
Fengjia Xi, Haoyu Sun, Hui Peng, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 171) with videos related to
Sort By:
Page
of 18
Chemosphere
|
April 22, 2018
A swinging seesaw as a novel model mechanism for time-dependent hormesis under dose-dependent stimulatory and inhibitory effects: A case study on the toxicity of antibacterial chemicals to Aliivibrio fischeri
Haoyu Sun, Edward J Calabrese, Min Zheng, et al.
International Journal of Biological Macromolecules
|
April 1, 2025
Polydopamine-mediated biointerfacial nanozyme as probiotic protective coating for IBD therapy
Tong Zhang, Chen Wang, Ting Du, et al.
Cancer Biology & Medicine
|
December 10, 2020
Trispecific killer engager 161519 enhances natural killer cell function and provides anti-tumor activity against CD19-positive cancers
Ying Cheng, Xiaodong Zheng, Xuefu Wang, et al.
Disease Markers
|
March 18, 2022
Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma
Hongda Guo, Songlin Jiang, Haoyu Sun, et al.
Frontiers in Immunology
|
April 28, 2023
Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager
Xinghui Xiao, Ying Cheng, Xiaodong Zheng, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
July 25, 2025
Investigation into the acute effects of various waveforms on tibial nerve stimulation for treating overactive bladder in cats
Dongsheng Shang, Haoyu Sun, Han Deng, et al.
Cancer Immunology Research
|
November 21, 2024
CD49a Targeting Enhances NK Cell Function and Antitumor Immunity
Yu Zhang, Yangyang Li, Zhengfeng Zhang, et al.
Frontiers in Immunology
|
January 31, 2024
Corrigendum: Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager
Xinghui Xiao, Ying Cheng, Xiaodong Zheng, et al.
Frontiers in Pharmacology
|
April 30, 2025
Safety and efficacy of intravesical instillation of botulinum toxin-A in the treatment of interstitial cystitis/bladder pain syndrome and overactive bladder: a systematic review and meta-analysis
Yongheng Zhou, Zitian He, Tianyu Xiang, et al.
JCI Insight
|
July 8, 2024
Hepatocyte-derived FGL1 accelerates liver metastasis and tumor growth by inhibiting CD8+ T and NK cells
Fengjia Xi, Haoyu Sun, Hui Peng, et al.
Page
of 18